Kingfisher Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $6.67M | Sell |
10,782
-469
| -4% | -$278K | 1.53% | 20 |
|
|
2024
Q2 | $6.22M | Sell |
11,251
-46
| -0.4% | -$26.4K | 1.45% | 17 |
|
|
2024
Q1 | $6.57M | Sell |
11,297
-76
| -0.7% | -$42.6K | 1.58% | 17 |
|
|
2023
Q4 | $6.04M | Sell |
11,373
-164
| -1% | -$79.4K | 1.57% | 14 |
|
|
2023
Q3 | $5.84M | Buy |
11,537
+23
| +0.2% | +$12.3K | 1.59% | 12 |
|
|
2023
Q2 | $6.01M | Sell |
11,514
-189
| -2% | -$102K | 1.57% | 14 |
|
|
2023
Q1 | $6.75M | Buy |
11,703
+20
| +0.2% | +$11.3K | 1.77% | 8 |
|
|
2022
Q4 | $6.43M | Buy |
11,683
+943
| +9% | +$500K | 1.71% | 7 |
|
|
2022
Q3 | $5.45M | Buy |
10,740
+2,218
| +26% | +$1.24M | 1.5% | 13 |
|
|
2022
Q2 | $4.63M | Buy |
8,522
+322
| +4% | +$177K | 1.32% | 18 |
|
|
2022
Q1 | $4.84M | Buy |
8,200
+133
| +2% | +$76.4K | 1.25% | 17 |
|
|
2021
Q4 | $5.38M | Buy |
8,067
+283
| +4% | +$177K | 1.24% | 18 |
|
|
2021
Q3 | $4.45M | Buy |
7,784
+206
| +3% | +$113K | 1.16% | 25 |
|
|
2021
Q2 | $3.82M | Buy |
7,578
+322
| +4% | +$152K | 0.97% | 32 |
|
|
2021
Q1 | $3.31M | Buy |
7,256
+565
| +8% | +$270K | 0.93% | 32 |
|
|
2020
Q4 | $3.12M | Buy |
6,691
+537
| +9% | +$252K | 0.94% | 30 |
|
|
2020
Q3 | $2.72M | Buy |
6,154
+396
| +7% | +$164K | 0.98% | 28 |
|
|
2020
Q2 | $2.09M | Buy |
5,758
+4
| +0.1% | +$1.34K | 0.93% | 31 |
|
|
2020
Q1 | $1.63M | Buy |
5,754
+426
| +8% | +$134K | 0.84% | 35 |
|
|
2019
Q4 | $1.73M | Buy |
5,328
+9
| +0.2% | +$2.73K | 0.81% | 42 |
|
|
2019
Q3 | $1.55M | Sell |
5,319
-7
| -0.1% | -$2K | 0.92% | 39 |
|
|
2019
Q2 | $1.56M | Buy |
5,326
+225
| +4% | +$62K | 0.97% | 39 |
|
|
2019
Q1 | $1.4M | Sell |
5,101
-68
| -1% | -$16.9K | 0.89% | 44 |
|
|
2018
Q4 | $1.16M | Sell |
5,169
-6,272
| -55% | -$1.47M | 0.82% | 45 |
|
|
2018
Q3 | $2.79M | Buy |
11,441
+159
| +1% | +$36.6K | 1.5% | 14 |
|
|
2018
Q2 | $2.34M | Sell |
11,282
-514
| -4% | -$109K | 1.48% | 18 |
|
|
2018
Q1 | $2.44M | Buy |
11,796
+48
| +0.4% | +$10.1K | 1.55% | 17 |
|
|
2017
Q4 | $2.23M | Sell |
11,748
-176
| -1% | -$33.7K | 1.42% | 18 |
|
|
2017
Q3 | $2.26M | Sell |
11,924
-396
| -3% | -$71.7K | 1.49% | 17 |
|
|
2017
Q2 | $2.15M | Buy |
12,320
+143
| +1% | +$24K | 1.46% | 18 |
|
|
2017
Q1 | $1.87M | Buy |
12,177
+514
| +4% | +$78.6K | 1.35% | 20 |
|
|
2016
Q4 | $1.65M | Sell |
11,663
-127
| -1% | -$18.7K | 1.24% | 24 |
|
|
2016
Q3 | $1.88M | Sell |
11,790
-489
| -4% | -$75.4K | 1.31% | 20 |
|
|
2016
Q2 | $1.81M | Sell |
12,279
-430
| -3% | -$63.5K | 1.2% | 30 |
|
|
2016
Q1 | $1.8M | Buy |
12,709
+43
| +0.3% | +$5.76K | 1.13% | 30 |
|
|
2015
Q4 | $1.8M | Sell |
12,666
-186
| -1% | -$24.8K | 1.06% | 30 |
|
|
2015
Q3 | $1.57M | Sell |
12,852
-148
| -1% | -$19.3K | 1% | 34 |
|
|
2015
Q2 | $1.69M | Sell |
13,000
-289
| -2% | -$37.7K | 0.97% | 36 |
|
|
2015
Q1 | $1.78M | Buy |
13,289
+20
| +0.2% | +$2.58K | 0.92% | 38 |
|
|
2014
Q4 | $1.66M | Buy |
+13,269
| New | +$1.61M | 0.85% | 49 |
|
Other funds holding TMO
Kingfisher Capital's TMO Position: Q3 2024 in Review
Kingfisher Capital reduced its Thermo Fisher Scientific (TMO) stake by 4.2% in Q3 2024, selling an estimated $278K and leaving 10,782 shares worth $6.67M. The position accounts for 1.53% of the portfolio, ranked #20.
Kingfisher Capital first reported a position in TMO in Q4 2014 and has held it in 40 quarters since. The position peaked at $6.75M in Q1 2023. 2,568 funds tracked by Wall St. Rank hold TMO as of Q3 2024.
- Kingfisher Capital held 10,782 shares of Thermo Fisher Scientific worth $6.67M as of Q3 2024.
- Kingfisher Capital sold 469 Thermo Fisher Scientific shares in Q3 2024, an estimated $278K.
- Thermo Fisher Scientific made up 1.53% of Kingfisher Capital's portfolio in Q3 2024, its #20 holding.
- Kingfisher Capital first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 40 quarters since.
- Kingfisher Capital's Thermo Fisher Scientific position peaked at $6.75M in Q1 2023.
- 2,568 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.
Based on Kingfisher Capital's 13F filing for Q3 2024, filed 14 Nov 2024.